These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21911020)

  • 1. Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region.
    Maradei E; Perez Beascoechea C; Malirat V; Salgado G; Seki C; Pedemonte A; Bonastre P; D'Aloia R; La Torre JL; Mattion N; Rodríguez Toledo J; Bergmann IE
    Vaccine; 2011 Oct; 29(46):8230-40. PubMed ID: 21911020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
    Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
    Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a type O foot-and-mouth disease virus re-emerging in the year 2011 in free areas of the Southern Cone of South America and cross-protection studies with the vaccine strain in use in the region.
    Maradei E; Malirat V; Beascoechea CP; Benitez EO; Pedemonte A; Seki C; Novo SG; Balette CI; D'Aloia R; La Torre JL; Mattion N; Toledo JR; Bergmann IE
    Vet Microbiol; 2013 Mar; 162(2-4):479-490. PubMed ID: 23182909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular epidemiology of foot-and-mouth disease virus serotypes A and O from 1998 to 2004 in Turkey.
    Klein J; Parlak U; Ozyörük F; Christensen LS
    BMC Vet Res; 2006 Dec; 2():35. PubMed ID: 17144917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic.
    König GA; Palma EL; Maradei E; Piccone ME
    Vet Microbiol; 2007 Sep; 124(1-2):1-15. PubMed ID: 17475419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and genetic analyses of foot-and-mouth disease virus type A isolates for selection of candidate vaccine strain reveals emergence of a variant virus that is responsible for most recent outbreaks in India.
    Jangra RK; Tosh C; Sanyal A; Hemadri D; Bandyopadhyay SK
    Virus Res; 2005 Sep; 112(1-2):52-9. PubMed ID: 16022900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field outbreak strains of serotype O foot-and-mouth disease virus from India with a deletion in the immunodominant βG-βH loop of the VP1 protein.
    Das B; Sanyal A; Subramaniam S; Mohapatra JK; Pattnaik B
    Arch Virol; 2012 Oct; 157(10):1967-70. PubMed ID: 22707045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and antigenic site analysis of foot-and-mouth disease virus from pigs and cattle in Korea.
    Oem JK; Lee KN; Cho IS; Kye SJ; Park JY; Park JH; Kim YJ; Joo YS; Song HJ
    J Vet Sci; 2005 Jun; 6(2):117-24. PubMed ID: 15933431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomics of serotype Asia 1 foot-and-mouth disease virus isolates from India sampled over the last two decades.
    Mohapatra JK; Sanyal A; Hemadri D; Tosh C; Biswas S; Knowles NJ; Rasool TJ; Bandyopadhyay SK; Pattnaik B
    Virus Res; 2008 Sep; 136(1-2):16-29. PubMed ID: 18511143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of antigenic variants of Foot-and-Mouth Disease Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate.
    Maradei E; Malirat V; Beascoechea CP; Espinoza AM; Novo SG; Smitsaart E; Salgado G; Mattion N; Toledo JR; Bergmann IE
    Vaccine; 2014 May; 32(21):2446-51. PubMed ID: 24625343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of suitability of two serotype A candidate vaccine strains for inclusion in FMD vaccine in India.
    Mohapatra JK; Hemadri D; Rao TV; Sreenivasa BP; Subramaniam S; Sanyal A; Periyasamy TR; Singh NK; Pattnaik B; Venkataramanan R
    Vet Microbiol; 2008 Sep; 131(1-2):65-72. PubMed ID: 18394827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field.
    Sangula AK; Siegismund HR; Belsham GJ; Balinda SN; Masembe C; Muwanika VB
    Epidemiol Infect; 2011 Feb; 139(2):189-96. PubMed ID: 20334728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a high quality O
    Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
    Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic analysis of foot-and-mouth disease virus type O re-emerging in free areas of South America.
    Malirat V; de Barros JJ; Bergmann IE; Campos Rde M; Neitzert E; da Costa EV; da Silva EE; Falczuk AJ; Pinheiro DS; de Vergara N; Cirvera JL; Maradei E; Di Landro R
    Virus Res; 2007 Mar; 124(1-2):22-8. PubMed ID: 17056146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the recent outbreak of foot-and-mouth disease virus serotype SAT2 in Egypt.
    Kandeil A; El-Shesheny R; Kayali G; Moatasim Y; Bagato O; Darwish M; Gaffar A; Younes A; Farag T; Kutkat MA; Ali MA
    Arch Virol; 2013 Mar; 158(3):619-27. PubMed ID: 23132412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador.
    Duque H; Naranjo J; Carrillo C; Burbano A; Vargas J; Pauszek L; Olesen I; Sanchez-Vazquez MJ; Cosivi O; Allende RM
    Vaccine; 2016 Jul; 34(35):4140-4144. PubMed ID: 27395565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and antigenic characterization of Indian foot-and-mouth disease virus serotype O isolates collected during the period 2001 to 2012.
    Yuvaraj S; Madhanmohan M; Nagendrakumar SB; Kumar R; Subramanian BM; Mohapatra JK; Sanyal A; Pattnaik B; Srinivasan VA
    Infect Genet Evol; 2013 Jan; 13():109-15. PubMed ID: 23123825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies.
    Seki C; Robiolo B; Periolo O; Iglesias M; D'Antuono A; Maradei E; Barros V; La Torre J; Mattion N
    Vet Microbiol; 2009 Jan; 133(3):239-51. PubMed ID: 18774662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.